The number of BC PharmaCare covered hep C treatments has been increasing and so has the information gathered by the Hepatitis C Treatment Information Project. The Hep C TIP now has new pages dedicated to BC’s PharmaCare and the treatments that are covered by it. These pages are:
| Treatments | Targeted Genotype |
| Ribavirin with Pegylated Interferon (PEG/RBV) | 2 – 6 |
| Victrelis (boceprevir) | 1 |
| Galexos (simeprevir) | 1 |
| Sovaldi (sofosbuvir) | 1 – 3 |
| Harvoni (ledipasvir and sofosbuvir) | 1 |
For more information about currently approved hep C treatments in BC, new and emerging drugs, the drug approval process in Canada and BC, or hep C support programs, please visit PHCN’s Hepatitis C Treatment Information Project or email [email protected].